01—Abstract
Summary
Summary of the 8-K filed August 6, 2026. Cited figures are marked; the original filing is the authoritative source.
Resmed Inc. reported results for its fourth quarter and fiscal year ended June 30, 2026, in a press release furnished as Exhibit 99.1.
Fourth-quarter revenue rose 9% to $1,464 milliona (8% in constant currency), and GAAP diluted earnings per share increased 2% to $2.64. Non-GAAP diluted earnings per share rose 16% to $2.95. For the full fiscal year, revenue increased 10% to $5,653 million, GAAP diluted EPS was $10.43, and non-GAAP diluted EPS was $11.17, an increase of 17%.
Operating cash flow for the year was $1,806 millionb and free cash flow was $1,650 million. Fourth-quarter GAAP gross margin fell 200 basis points to 58.8%, reflecting $41.9 million of Astral field safety notification expenses, which the company excludes from its non-GAAP measures. GAAP income from operations declined 1% to $449 million, while non-GAAP income from operations rose 8% to $515 million.
Fourth-quarter free cash flow decreased 21% to $404 millionc. The board declared a quarterly cash dividend of $0.66 per share, a 10% increase over the prior quarterly dividend, with a record date of August 20, 2026 and payment on September 24, 2026.
The company also disclosed an agreement to sell its MatrixCare business, expected to close in the first quarter of fiscal 2027, and the completed acquisition of Noctrix Health. For fiscal 2027, the company is guiding to more than $1.85 billiond in capital returned to shareholders through share repurchases and dividends.
02—Key points
Key Highlights
- Q4 FY2026 revenue rose 9% to $1,464 million, or 8% in constant currency, with Americas revenue up 8% and Rest of World up 13% reported.
- GAAP diluted EPS was $2.64 in Q4, up 2%; non-GAAP diluted EPS was $2.95, up 16%.
- FY2026 revenue increased 10% to $5,653 million; GAAP operating margin was 33.4% and non-GAAP operating margin was 36.1%.
- Q4 GAAP gross margin declined 200 basis points to 58.8%, driven by $41.9 million of Astral field safety notification expenses; non-GAAP gross margin rose 90 basis points to 62.3%.
- Quarterly dividend increased 10% to $0.66 per share, with a record date of August 20, 2026 and payment on September 24, 2026.
- Agreed to sell the MatrixCare business, expected to close in Q1 fiscal 2027; completed the Noctrix Health acquisition.
- Guiding to more than $1.85 billion in capital returned to shareholders through share repurchases and dividends in FY2027.
03—Questions
Frequently Asked Questions
How did Resmed perform in the fourth quarter of fiscal 2026?
Revenue grew 9% to $1,464 million (8% in constant currency). GAAP income from operations declined 1% to $449 million, while non-GAAP income from operations increased 8% to $515 million. GAAP diluted EPS rose 2% to $2.64, and non-GAAP diluted EPS rose 16% to $2.95.
What drove the decline in GAAP gross margin?
GAAP gross margin fell 200 basis points to 58.8%, primarily due to $41.9 million of Astral field safety notification expenses. The company excludes these expenses from its non-GAAP gross margin, which increased 90 basis points to 62.3%.
What are the dividend terms announced by Resmed?
The board declared a quarterly cash dividend of $0.66 per share, a 10% increase over the previous quarterly dividend. The record date is August 20, 2026, the ex-dividend date is August 19, 2026, and payment is due September 24, 2026. CDI holders on the Australian Securities Exchange receive an equivalent amount in Australian currency.
What portfolio changes did Resmed disclose?
Resmed announced an agreement to sell its MatrixCare business, with closing expected in the first quarter of fiscal 2027. It also completed the acquisition of Noctrix Health, a medical device company selling FDA De Novo classified wearable therapeutics for Restless Leg Syndrome.
What is the company's capital return outlook for fiscal 2027?
Resmed is guiding to more than $1.85 billion in capital returned to shareholders through share repurchases and dividends during fiscal 2027. In fiscal 2026 it returned more than $1 billion through the same channels.
04—Continue